CoChat

Body mass index and breast cancer survival: a Mendelian randomization analysis

Open access
Guo, Qi, Burgess, Stephen, Turman, Constance, Bolla, Manjeet K, Wang, Qin, Lush, Michael, Abraham, Jean, Aittomäki, Kristiina, Andrulis, Irene L, Apicella, Carmel, Arndt, Volker, Barrdahl, Myrto, Benitez, Javier, Berg, Christine D, Blomqvist, Carl, Bojesen, Stig E, Bonanni, Bernardo, Brand, Judith S, Brenner, Hermann, Broeks, Annegien, Burwinkel, Barbara, Caldas, Carlos, Campa, Daniele, Canzian, Federico, Chang-Claude, Jenny, Chanock, Stephen J, Chin, Suet-Feung, Couch, Fergus J, Cox, Angela, Cross, Simon S, Cybulski, Cezary, Czene, Kamila, Darabi, Hatef, Devilee, Peter, Diver, W Ryan, Dunning, Alison M, Earl, Helena M, Eccles, Diana M, Ekici, Arif B, Eriksson, Mikael, Evans, D Gareth, Fasching, Peter A, Figueroa, Jonine, Flesch-Janys, Dieter, Flyger, Henrik, Gapstur, Susan M, Gaudet, Mia M, Giles, Graham G, Glendon, Gord, Grip, Mervi, Gronwald, Jacek, Haeberle, Lothar, Haiman, Christopher A, Hall, Per, Hamann, Ute, Hankinson, Susan, Hartikainen, Jaana M, Hein, Alexander, Hiller, Louise, Hogervorst, Frans B, Holleczek, Bernd, Hooning, Maartje J, Hoover, Robert N, Humphreys, Keith, Hunter, David J, Hüsing, Anika, Jakubowska, Anna, Jukkola-Vuorinen, Arja, Kaaks, Rudolf, Kabisch, Maria, Kataja, Vesa, kConFab/AOCS Investigators, Knight, Julia A, Koppert, Linetta B, Kosma, Veli-Matti, Kristensen, Vessela N, Lambrechts, Diether, Le Marchand, Loic, Li, Jingmei, Lindblom, Annika, Lindström, Sara, Lissowska, Jolanta, Lubinski, Jan, Machiela, Mitchell J, Mannermaa, Arto, Manoukian, Siranoush, Margolin, Sara, Marme, Federik, Martens, John WM, McLean, Catriona, Menéndez, Primitiva, Milne, Roger L, Marie Mulligan, Anna, Muranen, Taru A, Nevanlinna, Heli, Neven, Patrick, Nielsen, Sune F, Nordestgaard, Børge G, Olson, Janet E, Perez, Jose IA, Peterlongo, Paolo, Phillips, Kelly-Anne, Poole, Christopher J, Pylkäs, Katri, Radice, Paolo, Rahman, Nazneen, Rüdiger, Thomas, Rudolph, Anja, Sawyer, Elinor J, Schumacher, Fredrick, Seibold, Petra, Seynaeve, Caroline, Shah, Mitul, Smeets, Ann, Southey, Melissa C, Tollenaar, Rob A E M, Tomlinson, Ian, Tsimiklis, Helen, Ulmer, Hans-Ulrich, Vachon, Celine, van den Ouweland, Ans MW, Van’t Veer, Laura J, Wildiers, Hans, Willett, Walter, Winqvist, Robert, Zamora, M Pilar, Chenevix-Trench, Georgia, Dörk, Thilo, Easton, Douglas F, García-Closas, Montserrat, Kraft, Peter, Hopper, John L, Zheng, Wei, Schmidt, Marjanka K, Pharoah, Paul DP · 2017 · International Journal of Epidemiology

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Background: There is increasing evidence that elevated body mass index (BMI) is associated with reduced survival for women with breast cancer. However, the underlying reasons remain unclear. We conducted a Mendelian randomization analysis to investigate a possible causal role of BMI in survival from breast cancer. Methods: We used individual-level data from six large breast cancer case-cohorts including a total of 36 210 individuals (2475 events) of European ancestry. We created a BMI genetic risk score (GRS) based on genotypes at 94 known BMI-associated genetic variants. Association between the BMI genetic score and breast cancer survival was analysed by Cox regression for each study separately. Study-specific hazard ratios were pooled using fixed-effect meta-analysis. Results: BMI genetic score was found to be associated with reduced breast cancer-specific survival for estrogen receptor (ER)-positive cases [hazard ratio (HR) = 1.11, per one-unit increment of GRS, 95% confidence interval (CI) 1.01-1.22, P = 0.03). We observed no association for ER-negative cases (HR = 1.00, per one-unit increment of GRS, 95% CI 0.89-1.13, P = 0.95). Conclusions: Our findings suggest a causal effect of increased BMI on reduced breast cancer survival for ER-positive breast cancer. There is no evidence of a causal effect of higher BMI on survival for ER-negative breast cancer cases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dyx131

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Genetic associations of BMI GRS and breast cancer survival for ER-positive cases. (A) Scatter plot of log hazard ratio of genetic associations with breast cancer survival for ER-positive cases against log odds ratio of association with BMI. Slope of the regression lines: inverse variance-weighted (dotted) and MR-Egger (dashed) provide an estimate of the predicted log hazard ratio per unit increase in BMI. (B) Funnel plot of minor allele frequency (MAF)-corrected log odds ratio of genetic associations with BMI against log hazard ratio per predicted unit increase in BMI on breast cancer survival for each genetic variant individually.
Figure 1 Genetic associations of BMI GRS and breast cancer survival for ER-positive cases. (A) Scatter plot of log hazard ratio of genetic associations with breast cancer survival for ER-positive cases against log odds ratio of association with BMI. Slope of the regression lines: inverse variance-weighted (dotted) and MR-Egger (dashed) provide an estimate of the predicted log hazard ratio per unit increase in BMI. (B) Funnel plot of minor allele frequency (MAF)-corrected log odds ratio of genetic associations with BMI against log hazard ratio per predicted unit increase in BMI on breast cancer survival for each genetic variant individually.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 67

Metadata

Authors
Guo, Q., Burgess, S., Turman, C., Bolla, M. K., Wang, Q., Lush, M., Abraham, J., Aittomäki, K., Andrulis, I. L., Apicella, C., Arndt, V., Barrdahl, M., Benitez, J., Berg, C. D., Blomqvist, C., Bojesen, S. E., Bonanni, B., Brand, J. S., Brenner, H., Broeks, A., Burwinkel, B., Caldas, C., Campa, D., Canzian, F., Chang-Claude, J., Chanock, S. J., Chin, S.-F., Couch, F. J., Cox, A., Cross, S. S., Cybulski, C., Czene, K., Darabi, H., Devilee, P., Diver, W. R., Dunning, A. M., Earl, H. M., Eccles, D. M., Ekici, A. B., Eriksson, M., Evans, D. G., Fasching, P. A., Figueroa, J., Flesch-Janys, D., Flyger, H., Gapstur, S. M., Gaudet, M. M., Giles, G. G., Glendon, G., Grip, M., Gronwald, J., Haeberle, L., Haiman, C. A., Hall, P., Hamann, U., Hankinson, S., Hartikainen, J. M., Hein, A., Hiller, L., Hogervorst, F. B., Holleczek, B., Hooning, M. J., Hoover, R. N., Humphreys, K., Hunter, D. J., Hüsing, A., Jakubowska, A., Jukkola-Vuorinen, A., Kaaks, R., Kabisch, M., Kataja, V., kConFab/AOCS Investigators, Knight, J. A., Koppert, L. B., Kosma, V.-M., Kristensen, V. N., Lambrechts, D., Le Marchand, L., Li, J., Lindblom, A., Lindström, S., Lissowska, J., Lubinski, J., Machiela, M. J., Mannermaa, A., Manoukian, S., Margolin, S., Marme, F., Martens, J. W., McLean, C., Menéndez, P., Milne, R. L., Marie Mulligan, A., Muranen, T. A., Nevanlinna, H., Neven, P., Nielsen, S. F., Nordestgaard, B. G., Olson, J. E., Perez, J. I., Peterlongo, P., Phillips, K.-A., Poole, C. J., Pylkäs, K., Radice, P., Rahman, N., Rüdiger, T., Rudolph, A., Sawyer, E. J., Schumacher, F., Seibold, P., Seynaeve, C., Shah, M., Smeets, A., Southey, M. C., Tollenaar, R. A. E. M., Tomlinson, I., Tsimiklis, H., Ulmer, H.-U., Vachon, C., van den Ouweland, A. M., Van’t Veer, L. J., Wildiers, H., Willett, W., Winqvist, R., Zamora, M. P., Chenevix-Trench, G., Dörk, T., Easton, D. F., García-Closas, M., Kraft, P., Hopper, J. L., Zheng, W., Schmidt, M. K., & Pharoah, P. D.
Affiliations
  • University of Cambridge (GB)
  • Harvard University (US)
  • University of Helsinki (FI)
  • Mount Sinai Hospital (CA)
  • The University of Melbourne (AU)
  • German Cancer Research Center (DE)
  • Spanish National Cancer Research Centre (ES)
  • Division of Cancer Epidemiology and Genetics (US)
  • University of Copenhagen (DK)
  • European Institute of Oncology (IT)
  • Karolinska Institutet (SE)
  • The Netherlands Cancer Institute (NL)
  • University of Pisa (IT)
  • Mayo Clinic (US)
  • University of Sheffield (GB)
  • Pomeranian Medical University (PL)
  • Leiden University Medical Center (NL)
  • American Cancer Society (US)
  • University of Southampton (GB)
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Manchester Academic Health Science Centre (GB)
  • University of California, Los Angeles (US)
  • Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany,
  • Herlev Hospital (DK)
  • Oulu University Hospital (FI)
  • University of Southern California (US)
  • University of Massachusetts Amherst (US)
  • University of Eastern Finland (FI)
  • University of Warwick (GB)
  • Krebsregister Saarland (DE)
  • Erasmus MC Cancer Institute (NL)
  • Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland,
  • Oslo University Hospital (NO)
  • VIB-KU Leuven Center for Cancer Biology (BE)
  • University of Hawaii Cancer Center, Honolulu, HI, USA,
  • The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
  • Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland,
  • Heidelberg University (DE)
  • The Alfred Hospital (AU)
  • University Health Network (CA)
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada,
  • Universitair Ziekenhuis Leuven (BE)
  • IFOM (IT)
  • NordLab (FI)
  • Institute of Cancer Research (GB)
  • Guy's Hospital (GB)
  • Centre for Human Genetics (GB)
  • Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands,
  • Division of Molecular Pathology, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands,
  • Hospital Universitario La Paz (ES)
  • QIMR Berghofer Medical Research Institute (AU)
  • Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia,
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA,
  • Vanderbilt University (US)
Corresponding author
Guo, Qi
ORCID
Venue
International Journal of Epidemiology
Published
2017-10-09
Volume
46
Issue
6
Pages
1814-1822
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2613921192
Cited by
64
References
24
Citations by year
2026: 5 · 2025: 3 · 2024: 7 · 2023: 11 · 2022: 11 · 2021: 5 · 2020: 10 · 2019: 3 · 2018: 9
FWCI
2.65
Type
journal article
Language
en
Open access
Locations
  • International Journal of Epidemiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, cc-by)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
  • UEF eRepo (University of Eastern Finland) (acceptedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • Explore Bristol Research (submittedVersion, cc-by)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion, cc-by)
  • Bristol Research (University of Bristol) (submittedVersion, cc-by)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
Funders
  • Wellcome Trust (204623/Z/16/Z, 100114)
  • Francis Crick Institute (10124)
  • Cancer Research UK (A7572, 19187, C1287‐A10118, 16561, 15106, C1287/ A12014, A11699, A16561, 10124, 16942)
  • National Institute for Health and Care Research (NF-SI-0512-10165, NF-SI-0515-10090, NF-SI-0611-10154)
  • British Heart Foundation (RG/08/014/24067)
  • Medical Research Council (MR/L003120/1)
  • National Cancer Institute (P50CA116201)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Keywords
body mass index, breast cancer survival, estrogen receptor-positive breast cancer, estrogen receptor-negative breast cancer, obesity, breast cancer-specific survival
MeSH terms
Breast Neoplasms, Europe, Female, Humans, Receptors, Estrogen, Risk Factors, Genetic Variation, Meta-Analysis as Topic, Causality, Body Mass Index, Survival Analysis, Risk Assessment, Polymorphism, Single Nucleotide, White People, Mendelian Randomization Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Body mass index and breast cancer survival: a Mendelian randomization analysis. https://app.cochat.ai/papers/10.1093/ije/dyx131
The paper
Guo, Q., Burgess, S., Turman, C., Bolla, M. K., Wang, Q., Lush, M., Abraham, J., Aittomäki, K., Andrulis, I. L., Apicella, C., Arndt, V., Barrdahl, M., Benitez, J., Berg, C. D., Blomqvist, C., Bojesen, S. E., Bonanni, B., Brand, J. S., Brenner, H., . . . Pharoah, P. D. (2017). Body mass index and breast cancer survival: a Mendelian randomization analysis. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyx131

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.